A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer

A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer. Criscitiello, C.; Bayar, M. A.; Curigliano, G.; Symmans, F. W.; Desmedt, C.; Bonnefoi, H.; Sinn, B.; Pruneri, G.; Vicier, C.; Pierga, J. Y.; Denkert, C.; Loibl, S.; Sotiriou, C.; Michiels, S.; André, F.. Ann Oncol. 2018; 162-169: p.162-169. doi:10.1093/annonc/mdx691
Article